Pancreatic Cancer Research

ResearcherJiangsu Province HospitalActive in the last 2 years

Pengbo Zhang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-8519-3125; OpenAlex author ID A5100606072. Sources: OpenAlex.

Their work

Papers
6 (first author 1, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
21
Papers, trials and grants by year

2017: 1 paper · 2018: none · 2019: 2 papers · 2020: 1 paper · 2021: 1 paper · 2022: none · 2023: none · 2024: 1 paper

Papers 6

  1. hsa_circ_0007919 promotes pancreatic cancer metastasis by modulating Sp1-mediated THBS1 transcription. Last author DOI 10.1096/fj.202302422rr↗
  2. DUOX2 As a Potential Prognostic Marker which Promotes Cell Motility and Proliferation in Pancreatic Cancer. First author DOI 10.1155/2021/6530298↗
  3. A novel antisense lncRNA NT5E promotes progression by modulating the expression of SYNCRIP and predicts a poor prognosis in pancreatic cancer. Co-author DOI 10.1111/jcmm.15718↗
  4. The RNA m6A methyltransferase METTL3 promotes pancreatic cancer cell proliferation and invasion. Co-author DOI 10.1016/j.prp.2019.152666↗
  5. LncRNA BANCR Promotes Pancreatic Cancer Tumorigenesis via Modulating MiR-195-5p/Wnt/β-Catenin Signaling Pathway. Co-author DOI 10.1177/1533033819887962↗
  6. Deubiquitinase USP9X promotes cell migration, invasion and inhibits apoptosis of human pancreatic cancer. Co-author DOI 10.3892/or.2017.6050↗

Closest collaborators

The 21 strongest of 21 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Meng Cao · 4 shared papers, 2019–2021 · strength 0.39
  2. Guodong Shi · 4 shared papers, 2019–2021 · strength 0.39
  3. Baobao Cai · 4 shared papers, 2019–2021 · strength 0.39
  4. Kuirong Jiang · 4 shared papers, 2019–2021 · strength 0.39
  5. Lei Xu · 2 shared papers, 2020–2024 · strength 0.28
  6. Zipeng Lu · 3 shared papers, 2019–2020 · strength 0.26
  7. Tianfang Xia · 3 shared papers, 2019–2020 · strength 0.26
  8. Xinquan Wu · 3 shared papers, 2019–2020 · strength 0.26
  9. Yi Miao · 3 shared papers, 2019–2020 · strength 0.26
  10. Zeqiang Ren · 2 shared papers, 2017–2024 · strength 0.25
  11. Shouji Cao · 2 shared papers, 2020–2021 · strength 0.21
  12. Qun Chen · 2 shared papers, 2020–2021 · strength 0.21
  13. Pengfei Wu · 2 shared papers, 2019–2021 · strength 0.21
  14. Xiao Ma · 1 shared paper, 2024 · strength 0.19
  15. Lei Chen · 2 shared papers, 2019–2020 · strength 0.17
  16. Pengfei Wu · 2 shared papers, 2019–2020 · strength 0.17
  17. Jingjing Zhang · 2 shared papers, 2019 · strength 0.17
  18. Wanli Ge · 1 shared paper, 2021 · strength 0.12
  19. Yi Miao · 1 shared paper, 2021 · strength 0.12
  20. Yi Zhang · 1 shared paper, 2017 · strength 0.06
  21. Li Liu · 1 shared paper, 2017 · strength 0.06

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.